Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|August 22, 2006
Review article: prebiotics in the gastrointestinal tractS Macfarlane, G T Macfarlane, J H CummingsCurrent Issues in Intestinal Microbiology|April 15, 2003
Intestinal bacteria and ulcerative colitisJ H Cummings, G T Macfarlane, S MacfarlaneGut|December 20, 2003
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune responseE Furrie, S Macfarlane, J H Cummings, et al.The Journal of Applied Bacteriology|February 1, 1990
Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous cultureG T Macfarlane, S Hay, S Macfarlane, et al.The Journal of Applied Bacteriology|November 1, 1989
Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture systemG T Macfarlane, J H Cummings, S Macfarlane, et al.Alimentary Pharmacology & Therapeutics|August 21, 2013
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover studyS Macfarlane, S Cleary, B Bahrami, et al.Journal of Applied Microbiology|September 29, 1998
Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteriaD F Newton, J H Cummings, S Macfarlane, et al.Current Microbiology|May 1, 1997
Starch utilization by Bacteroides ovatus isolated from the human large intestineB A Degnan, S Macfarlane, M E Quigley, et al.The British Journal of Nutrition|May 10, 2005
Mucosal bacteria in ulcerative colitisS Macfarlane, E Furrie, A Kennedy, et al.Current Pharmaceutical Design|May 16, 2009
The gut microbiota in inflammatory bowel diseaseG T Macfarlane, K L Blackett, T Nakayama, et al.Pageof 11